Loading organizations...
Key people at Msd Capital.
MSD Capital operates as a private investment and asset management firm, primarily focused on growing the wealth of Michael Dell and his family. The firm employs a multi-disciplinary investment strategy, deploying capital across various asset classes globally. This approach aims to maximize long-term capital appreciation through a diverse portfolio of investments.
Michael Dell established MSD Capital in 1998 with the specific purpose of managing his family's substantial fortune. The founding insight was to create a dedicated vehicle for strategic private investments and asset oversight, leveraging Dell’s entrepreneurial success into sophisticated financial management. This move allowed for a centralized and professional approach to wealth preservation and growth.
The firm's core client is Michael Dell and his family, for whom it acts as a comprehensive financial steward. MSD Capital’s vision is centered on the enduring growth and diversification of this family wealth, strategically navigating global markets to identify and capitalize on long-term opportunities. Its mission remains focused on robust asset management for its sole principal.
Key people at Msd Capital.
MSD Capital is the private investment firm managing the assets of Michael Dell, founder of Dell Technologies, and his family. The firm pursues a multi-asset investment strategy with a focus on long-term capital appreciation across private capital (including control buyouts and minority stakes), credit, growth equity in founder-led technology and healthcare companies, and real estate. Its investment philosophy emphasizes flexibility, long-term partnerships, and risk-adjusted returns, often investing alongside founders and family businesses. MSD Capital impacts the startup ecosystem primarily through its growth equity investments in high-growth, founder-led private technology companies, spanning enterprise, consumer, fintech, and healthcare sectors[1][2][3].
Founded in 1998 by Michael Dell, MSD Capital was established to manage and grow the Dell family’s wealth through diversified investments. Over time, it evolved from a family office into a sophisticated investment firm with multiple specialized teams focusing on public and private equities, credit, and real estate. In 2009, MSD Partners was created to allow external investors to co-invest alongside the Dell family. In 2023, MSD Partners merged with BDT & Company, forming BDT & MSD Partners, a merchant bank serving business owners and long-term investors globally[1][2][3][6].
MSD Capital rides the trend of long-term, founder-aligned investing in technology and healthcare sectors, where innovation and market disruption create significant growth opportunities. The timing is favorable due to increasing demand for patient capital and strategic partnerships that support scaling companies beyond early venture stages. By providing flexible capital and operational support, MSD influences the ecosystem by enabling founder-led companies to grow sustainably and compete globally. Its merger with BDT & Company expands its advisory capabilities, positioning it as a key player in merchant banking for family and founder businesses[1][2][6].
Looking ahead, MSD Capital is likely to deepen its focus on high-growth, founder-led technology and healthcare companies while continuing to leverage its multi-asset platform to capture diverse opportunities. The firm’s influence may grow as it integrates merchant banking services through BDT & MSD Partners, offering strategic advisory alongside capital. Trends such as digital transformation, healthcare innovation, and sustainable real estate development will shape its investment priorities. MSD’s long-term, flexible capital model positions it well to adapt to evolving market dynamics and maintain its role as a trusted partner for founders and family businesses.
This outlook ties back to MSD Capital’s founding mission of preserving and growing the Dell family’s wealth through disciplined, diversified, and founder-aligned investing.
Msd Capital has more than 26 tracked investments across 24 companies. The latest tracked deal is $30.0M Series A in Tahoe Therapeutics in August 2025.
